High-dose Cyclophosphamide for Severe Refractory Crohn Disease

NCT01836289 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Too difficult to recruit given new Crohn's medications approved

Conditions

Interventions

Sponsor

Johns Hopkins University